You just read:

OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

Oct 13, 2016, 07:30 ET